Rafael Sirera

3.6k citations
83 papers · 2.7k indexed · 1 hit paper · h-index 26
Topics
Lung Cancer Treatments and Mutations (18 papers)Cancer Genomics and Diagnostics (16 papers)Cancer Immunotherapy and Biomarkers (12 papers)
Journals
Journal of Clinical OncologySHILAP Revista de lepidopterologíaBlood
Partner nations
SpainNorwayUnited States

In The Last Decade

Rafael Sirera

81 papers receiving 2.7k citations

Hit Papers

The Role of Tumor Stroma in Cancer Progression and Progno...20102026201520202010100200300400500

Peers

Rafael Sirera
Comparison fields: 5 of 146
  • Molecular Biology 1.3k
  • Oncology 1.1k
  • Cancer Research 920
  • Pulmonary and Respiratory Medicine 765
  • Immunology 324
Replace Yoon Jin with:
Yoon Jin South Korea
Min Tao China
Ling Guo China
Thomas Bauernhofer Austria
Kosei Maemura Japan
Hiroyuki Hamakawa Japan
Laura Mercatali Italy
Ralph J. Hauke United States
Yue Zhao China
Hanxiao Xu China
Rafael Sirera relative to Yoon Jin South Korea Yoon Jin's profile →
Citations per field
00.5×1.5×
Yoon Jin · 1×
Citations per year

Countries citing papers authored by Rafael Sirera

Since Specialization
Citations

This map shows the geographic impact of Rafael Sirera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rafael Sirera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rafael Sirera more than expected).

Fields of papers citing papers by Rafael Sirera

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rafael Sirera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rafael Sirera. The network helps show where Rafael Sirera may publish in the future.

Co-authorship network of co-authors of Rafael Sirera

This figure shows the co-authorship network connecting the top 25 collaborators of Rafael Sirera. A scholar is included among the top collaborators of Rafael Sirera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rafael Sirera. Rafael Sirera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 4
3 17
4 34
5 23
6 28
7 15
8 75
9 69
10 1
11 32
12 22
13 69
14 4
15 0
16 5
17
The Role of Tumor Stroma in Cancer Progression and Prognosis: Emphasis on Carcinoma-Associated Fibroblasts and Non-small Cell Lung Cancerbreakdown →
525
18 5
19 22
20 13

About Rafael Sirera

Rafael Sirera is a scholar working on Cancer Research, Oncology and Internal Medicine, having authored 83 papers that have together received 2.7k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (18 papers), Cancer Genomics and Diagnostics (16 papers) and Cancer Immunotherapy and Biomarkers (12 papers). The work is most often cited by research in Cancer Research (920 citations), Oncology (1.1k citations) and Pulmonary and Respiratory Medicine (765 citations). Rafael Sirera has collaborated with scholars based in Spain, Norway and United States. Frequent co-authors include Carlos Camps, Roy M. Bremnes, Samer Al‐Saad, Lill‐Tove Busund, Sigve Andersen, Khalid Al‐Shibli, Tom Dønnem, Ana Blasco, Eloísa Jantus‐Lewintre and Christian Rolfo. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026